Agilent Technologies (NYSE:A – Get Rating) issued its quarterly earnings data on Tuesday. The medical research company reported $1.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.12 by $0.01, MarketWatch Earnings reports. The business had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.62 billion. Agilent Technologies had a net margin of 18.70% and a return on equity of 27.04%. The firm’s quarterly revenue was up 5.4% on a year-over-year basis. During the same quarter last year, the business earned $0.97 EPS.
Agilent Technologies stock opened at $120.38 on Thursday. Agilent Technologies has a fifty-two week low of $112.64 and a fifty-two week high of $179.57. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.64 and a current ratio of 2.19. The stock has a market cap of $36.16 billion, a P/E ratio of 30.55, a price-to-earnings-growth ratio of 2.80 and a beta of 1.06. The firm’s fifty day moving average price is $126.88 and its 200-day moving average price is $139.14.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 27th. Shareholders of record on Tuesday, July 5th will be given a dividend of $0.21 per share. The ex-dividend date is Friday, July 1st. This represents a $0.84 annualized dividend and a yield of 0.70%. Agilent Technologies’s payout ratio is presently 21.32%.
In other news, SVP Michael Tang sold 1,210 shares of the stock in a transaction dated Friday, March 18th. The stock was sold at an average price of $136.21, for a total transaction of $164,814.10. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
Several hedge funds have recently bought and sold shares of the business. Ironwood Wealth Management LLC. grew its holdings in Agilent Technologies by 142.5% in the second quarter. Ironwood Wealth Management LLC. now owns 485 shares of the medical research company’s stock worth $72,000 after purchasing an additional 285 shares during the period. Morgan Stanley increased its holdings in shares of Agilent Technologies by 2.9% during the second quarter. Morgan Stanley now owns 1,154,775 shares of the medical research company’s stock valued at $170,688,000 after acquiring an additional 33,059 shares in the last quarter. Sequoia Financial Advisors LLC purchased a new position in shares of Agilent Technologies in the 4th quarter worth about $245,000. Stifel Financial Corp increased its stake in Agilent Technologies by 2.2% during the 4th quarter. Stifel Financial Corp now owns 28,936 shares of the medical research company’s stock valued at $4,619,000 after purchasing an additional 632 shares in the last quarter. Finally, Advisors Asset Management Inc. purchased a new position in Agilent Technologies in the fourth quarter worth about $240,000.
About Agilent Technologies (Get Rating)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- Dentsply Stock is Repricing Itself
- Is Zoom Video (NASDAQ: ZM) Starting To Bottom Out?
- Short-Covering Begins In Big Lots
- Institutions Ring The Register On Toll Brothers Stock
- Agilent Technologies Is Bottoming But Don’t Buy It Yet
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.